Drawing for Serial No. 90902229

USPTO serial 90902229

Serial No. 90902229

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
LUEKEN, ABIGAIL JOSEPHINE
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with Serial No. 90902229?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Roger H. Bora

Roger H. Bora THOMPSON HINE LLP10050 INNOVATION DRIVE, SUITE 400MIAMISBURG, OH 45342United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of sexual dysfunction and sexual disorders; pharmaceutical preparations for sexual dysfunction and sexual disorders, namely, for the treatment of erectile dysfunction (ED); pharmaceutical preparations and substances for the treatment of ophthalmological and ocular diseases and disorders; pharmaceuticals preparations for treating ophthalmic conditions and eye diseases and eye conditions; pharmaceutical preparations for treating ophthalmic conditions and eye diseases and conditions, in particular dry eyes; topical ophthalmic pharmaceutical preparations; topical ophthalmic pharmaceutical preparations for the relief of the signs and symptoms of dry eye diseaseACTIVE—
042Biotechnological research and developmental services; pharmaceutical research services; conducting clinical trials for othersACTIVE—
044Providing medical information about sexual dysfunction and disorders and treatments for sexual dysfunction and disorders; providing medical information about ophthalmological and ocular diseases and disorders and treatments for sameACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Oct 9, 2025MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 9, 2025ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 15, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 15, 2024EX4GSOU EXTENSION 4 GRANTED—
Aug 15, 2024EXT4SOU EXTENSION 4 FILED—
Aug 15, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 7, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 6, 2024EX3GSOU EXTENSION 3 GRANTED—
Mar 6, 2024AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Feb 28, 2024EXT3SOU EXTENSION 3 FILED—
Feb 28, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 27, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 25, 2023EX2GSOU EXTENSION 2 GRANTED—
Jul 25, 2023EXT2SOU EXTENSION 2 FILED—
Jul 25, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 7, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 3, 2023EX1GSOU EXTENSION 1 GRANTED—
Feb 3, 2023EXT1SOU EXTENSION 1 FILED—
Feb 3, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 30, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 5, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 5, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 15, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 1, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 27, 2022DOCKASSIGNED TO EXAMINER—
Oct 13, 2021MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Oct 12, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 28, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance